100%(1)Il 100% ha trovato utile questo documento (1 voto)
129 visualizzazioni3 pagine
Pharmacists have the opportunity to have their say on the way pharmacy services are delivered for people living in aged care and Community Residential Support services. DHBNZ and Pharmac documents will contribute to the 2011 PSA between DHBs and community pharmacists. Pharmacists have until 30 November 2010 to provide their feedback, either through a website or by emailing the completed survey.
Pharmacists have the opportunity to have their say on the way pharmacy services are delivered for people living in aged care and Community Residential Support services. DHBNZ and Pharmac documents will contribute to the 2011 PSA between DHBs and community pharmacists. Pharmacists have until 30 November 2010 to provide their feedback, either through a website or by emailing the completed survey.
Copyright:
Attribution Non-Commercial (BY-NC)
Formati disponibili
Scarica in formato PDF, TXT o leggi online su Scribd
Pharmacists have the opportunity to have their say on the way pharmacy services are delivered for people living in aged care and Community Residential Support services. DHBNZ and Pharmac documents will contribute to the 2011 PSA between DHBs and community pharmacists. Pharmacists have until 30 November 2010 to provide their feedback, either through a website or by emailing the completed survey.
Copyright:
Attribution Non-Commercial (BY-NC)
Formati disponibili
Scarica in formato PDF, TXT o leggi online su Scribd
BY RAJESH KUMAR Pharmacists have the opportunity to have their
say on the way pharmacy services are delivered for people living in aged care and community residential support services. DHB New Zealand has released two discussion documents on the subject and is inviting views of consumers, pharmacists, carers and interested sector groups about how pharmacy services currently cater for people in such facilities and what improvements should be made. The documents titled Community Pharmacy Service Options for People in Age related Residential Care and Community Pharmacy Service Options for People with Disabilities living in Community Residential Support services are available through the DHB NZ website here. Pharmacists have until 30 November 2010 to provide their feedback, either through a website or by emailing the completed survey to PharmacyARRC@dhbnz.org.nz for the age-related residential care survey; or use a website or email PharmacyCommunity@dhbnz.org.nz for the community residential support services survey.
Pharmac also inviting feedback Concurrent to the above, Pharmac is also
inviting pharmacy feedback on the review of Pharmaceutical Schedule rules related to close control, distribution of special foods and higher cost products to patients following recommendation by the Pharmacy Services Steering Group (See further below). The Pharmaceutical Society is encouraging all pharmacists to read all the documents (Pharmac and DHBNZ) and provide feedback before 30 November. “This is your opportunity to influence the direction of a key part of the Pharmacy Services Agreement (PSA),” chief pharmacist advisor Euan Galloway says. The DHBNZ and Pharmac documents will contribute to the 2011 PSA between DHBs and community pharmacists. The process is being overseen by a steering group, representing DHBs, Pharmac, pharmacies, primary care and the Ministry of Health. DHBs’ spokesperson Sharon Kletchko, in a written statement, says it is the first time in many years that a review has been carried out that looks at the needs of specific groups of people with high health needs, medicine use, hospital admissions and care requirements. “We want to understand more about how, and how well, pharmacy services currently support best health and wellbeing outcomes for residents and whether a new or revised service model could operate more effectively and efficiently,” she says. The DHBs also intend to make better use of pharmacists’ clinical skills through medication management services and want to align these with the new pharmacy contract scheduled to come into force on 1 September next year. The project is supposed to go through three stages between October 2010 and May 2011. The first two stages provide opportunities to hear the views of people living in residential care as well as key members of the multidisciplinary team: such as practitioners, pharmacists and facility staff and national professional organisations and advocacy groups. After consideration of the discussion document feedback, a formal consultation proposal will be released following which a preferred service model will be finalised. In the third phase, DHBs will consult pharmacy agents on service directions for the pharmacy agreement from 1 September 2011 and develop an agreement package. DHBs also want to consult on improving the design of the pharmacy service model. The current model includes dispensing and supply of medications, provision of advice and counselling, maintenance of patient records, compliance with legislative requirements, and maintenance of linkages with related professional services. These services are currently paid for on a fee-for- service basis, with each prescription item attracting a fee of $5.30 plus 4% mark up. “We want to understand whether the current service, funding and contracting design is the most effective way to provide services to the people in age residential care who have high health needs, are on multiple medications, and may have frequent hospital admissions,” the consultation document on aged care services says. “We are interested in your feedback on design options that might be safer, more effective in using pharmacists’ clinical skills and provide better value within the funding available.” Dr Kletchko hopes the discussion documents will be circulated widely throughout the sector and affected individuals and groups will take the time to complete the survey questions. “People in age related care facilities and supported accommodation represent a significant percentage of pharmaceutical consumers. They are often frail and vulnerable and without close advocates so it is important their voice is heard,” she says. Review of Pharmaceutical Schedule rules Pharmac is also inviting pharmacy feedback on the review of Pharmaceutical Schedule rules related to Close Control, distribution of special foods and higher cost products to patients following recommendation by the Pharmacy Services Steering Group. The group comprising representatives of community pharmacy, DHB, Pharmac, Ministry of Health and primary care has agreed to five strategic projects that will contribute to the shape of the 2011 Community PSA. This review covers three of them. Pharmacists have until 30 November to send their feedback either by email to schedule.review@pharmac.govt.nz or by fax (04 460 4995) or mail (PO Box 10-254, Wellington 6011). They can also complete the survey online Pharmac will consider the feedback in December and expects that proposals for each project will be issued for consultation in late January 2011, with a formal consultation with the sector throughout February 2011. The Pharmaceutical Schedule rules being reviewed to determine whether the current Close Control rules are effective in managing access to certain pharmaceuticals for eligible patients, and if changes are required, consider which other services should or could be specifically reimbursed; examine options for the distribution of special foods to patients and review the mechanisms for distributing higher cost products to eligible patients. The review follows on from Pharmac’s pharmaceutical subsidy eligibility & delivery review in October last year and the January 2010 Special Foods consultation proposal to change access criteria and funding for a number of special foods. Pharmac says the recent changes announced by the government to regulations under the Medicines Act 1981 are not included in the scope of this consultation document. The timing of the above consultation coincides with the earlier mentioned DHB reviews of community pharmacy services to aged related residential care and community supported accommodation. This is to enable people to consider the DHB and Pharmac discussion documents together, because of the linkages between them. Contact Rachel Mackay on 04 9167508, 021 911 865, or rachel.mackay@pharmac.govt.nz for any clarification